| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HUP.1081 |
| P698 | PubMed publication ID | 20041478 |
| P50 | author | Melissa Hasty | Q117224677 |
| Eduard Vieta | Q20090640 | ||
| Michael Berk | Q30504747 | ||
| Francesc Colom | Q45741583 | ||
| Lesley Berk | Q58456831 | ||
| Karen Hallam | Q63912539 | ||
| Craig Macneil | Q91151588 | ||
| P2860 | cites work | Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication | Q22253024 |
| Clinical factors associated with treatment noncompliance in euthymic bipolar patients | Q28138392 | ||
| Antipsychotic medication adherence: is there a difference between typical and atypical agents? | Q28214337 | ||
| Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders | Q28269677 | ||
| Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder | Q28270795 | ||
| Using drug claims data to assess the relationship of medication adherence with hospitalization and costs | Q30652843 | ||
| Insight in psychosis: an elusive target | Q33541981 | ||
| Development of the treatment attitudes questionnaire in bipolar disorder | Q33619879 | ||
| Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials | Q33975437 | ||
| Existential despair and bipolar disorder: the therapeutic alliance as a mood stabilizer | Q33990147 | ||
| Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications | Q34188583 | ||
| Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review | Q34574031 | ||
| Treatment non-adherence in affective disorders. | Q34592227 | ||
| Relapse into mania or depression following lithium discontinuation: a 7-year follow-up | Q35630088 | ||
| Enhancement of treatment adherence among patients with bipolar disorder | Q35682922 | ||
| A collaborative approach to the treatment alliance in bipolar disorder | Q35947326 | ||
| Psychological therapies for bipolar disorder: the role of model-driven approaches to therapy integration | Q36011838 | ||
| Role of treatment alliance in the clinical management of bipolar disorder: stronger alliances prospectively predict fewer manic symptoms | Q36104578 | ||
| Identifying and improving non-adherence in bipolar disorders. | Q36286408 | ||
| Psychotherapy for bipolar disorders - efficacy and effectiveness. | Q36427643 | ||
| Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics. | Q36432689 | ||
| Family-focused treatment of the suicidal bipolar patient | Q36624150 | ||
| Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder | Q36630501 | ||
| Greater cortical gray matter density in lithium-treated patients with bipolar disorder | Q36652360 | ||
| Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder. | Q36932832 | ||
| Improving treatment adherence in bipolar disorder: a review of current psychosocial treatment efficacy and recommendations for future treatment development | Q36951439 | ||
| A review of brief medication-adherence instruments used in patients with schizophrenia and bipolar disorder | Q36965871 | ||
| Setting the stage: from prodrome to treatment resistance in bipolar disorder | Q36995615 | ||
| Cognitive dysfunction in bipolar disorder: future place of pharmacotherapy. | Q37004409 | ||
| Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder | Q37152810 | ||
| Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment | Q37402290 | ||
| Reduced left anterior cingulate volumes in untreated bipolar patients | Q38449035 | ||
| Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients | Q38482836 | ||
| Factors associated with treatment nonadherence among US bipolar disorder patients | Q40146888 | ||
| Adherence to medication in bipolar disorder: a qualitative study exploring the role of patients' beliefs about the condition and its treatment | Q40175775 | ||
| Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization | Q40623890 | ||
| Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy | Q40661781 | ||
| Non-compliance--or how many aunts has Matilda? | Q40713330 | ||
| Lithium use and discontinuation in a health maintenance organization | Q41014056 | ||
| Attitudes regarding the collaborative practice model and treatment adherence among individuals with bipolar disorder | Q42668599 | ||
| Relapse and impairment in bipolar disorder | Q43514252 | ||
| Nonadherence with mood stabilizers: prevalence and predictors | Q43999454 | ||
| Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial. | Q44048838 | ||
| Treatment adherence with antipsychotic medications in bipolar disorder | Q44083784 | ||
| Do clinicians understand why individuals stop taking lithium? | Q44434685 | ||
| Factors associated with patients' knowledge of and attitudes towards treatment with lithium | Q44461941 | ||
| Suicide risk in bipolar disorder during treatment with lithium and divalproex | Q44586528 | ||
| Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study | Q44671658 | ||
| The effects of patient education in lithium therapy on quality of life and compliance | Q44699789 | ||
| Medication adherence skills training for middle-aged and elderly adults with bipolar disorder: development and pilot study | Q44871077 | ||
| Treatment adherence and illness insight in veterans with bipolar disorder | Q45332060 | ||
| Attitudinal Correlates of Lithium Compliance in Bipolar Affective Disorders | Q46071673 | ||
| Reduced amygdalar gray matter volume in familial pediatric bipolar disorder | Q46503065 | ||
| Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial. | Q46507616 | ||
| Knowledge and compliance towards lithium therapy among Chinese psychiatric patients in Hong Kong | Q47284665 | ||
| A randomized controlled trial of cognitive therapy for bipolar disorder: focus on long-term change. | Q47340715 | ||
| Lithium Maintenance: 1. A Standard Education Programme for Patients | Q48520352 | ||
| Psychoeducation of partners of bipolar-manic patients | Q49170246 | ||
| Impact of family burden and affective response on clinical outcome among patients with bipolar disorder. | Q50993460 | ||
| Patients' perceptions of information received about medication prescribed for bipolar disorder: implications for informed choice. | Q51908862 | ||
| Long-term effectiveness and cost of a systematic care program for bipolar disorder. | Q51918257 | ||
| Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. | Q51919569 | ||
| A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. | Q52974125 | ||
| A pilot study of concordance therapy for individuals with bipolar disorders who are non-adherent with lithium prophylaxis. | Q53660297 | ||
| Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study | Q53681960 | ||
| Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment | Q57612798 | ||
| Stabilizing the stabilizer: group psychoeducation enhances the stability of serum lithium levels | Q57612842 | ||
| A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission | Q57612892 | ||
| Predicting medication adherence in severe mental disorders | Q61054278 | ||
| Adherence to Treatment Regimen in a Lithium Carbonate Clinic | Q63869313 | ||
| Longitudinal outcome and medication noncompliance among manic patients with and without mood-incongruent psychotic features | Q67523136 | ||
| Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders | Q70729881 | ||
| Lithium-induced increase in human brain grey matter | Q73176044 | ||
| Early onset of lithium prophylaxis as a predictor of good long-term outcome | Q73257995 | ||
| GAMIAN-Europe/BEAM survey I--global analysis of a patient questionnaire circulated to 3450 members of 12 European advocacy groups operating in the field of mood disorders | Q73743945 | ||
| A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder | Q73918315 | ||
| Mortality of patients with mood disorders: follow-up over 34-38 years | Q74294155 | ||
| Effects of psychoeducational intervention for married patients with bipolar disorder and their spouses | Q74459922 | ||
| 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode | Q74541226 | ||
| Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder | Q79832852 | ||
| Factors that affect adherence to bipolar disorder treatments: a stated-preference approach | Q80362225 | ||
| Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up | Q80377909 | ||
| Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder | Q80400367 | ||
| GAMIAN-Europe/BEAM survey II: cross-national analysis of unemployment, family history, treatment satisfaction and impact of the bipolar disorder on life style | Q80995801 | ||
| Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders | Q81247827 | ||
| Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years | Q81333670 | ||
| Bipolar disorder: medication adherence and life contentment | Q81342816 | ||
| Effects of caregivers' perceived stigma and causal beliefs on patients' adherence to antidepressant treatment | Q81716500 | ||
| Predicting medication non-adherence in severe affective disorders | Q87454644 | ||
| P433 | issue | 1 | |
| P921 | main subject | bipolar disorder | Q131755 |
| patient | Q181600 | ||
| P304 | page(s) | 1-16 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Human Psychopharmacology | Q15751477 |
| P1476 | title | Enhancing medication adherence in patients with bipolar disorder | |
| P478 | volume | 25 |
| Q34433880 | Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularity |
| Q38156105 | Assessing medication adherence: options to consider |
| Q37415124 | Association between therapeutic alliance, care satisfaction, and pharmacological adherence in bipolar disorder |
| Q55424356 | Atypical antipsychotic agents; Peas in a pod or chalk and cheese? |
| Q38003196 | Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder |
| Q56039529 | Bipolar disorder |
| Q42631319 | Can a targeted psychological intervention be effective for young people following a first manic episode? Results from an 18-month pilot study |
| Q52656684 | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. |
| Q38184528 | Directions for future patient-centered and comparative effectiveness research for people with serious mental illness in a learning mental health care system |
| Q38376458 | Does Diagnosis Make a Difference? Estimating the Impact of an HIV Medication Adherence Intervention for Persons with Serious Mental Illness. |
| Q38003100 | Effectiveness of interventions to improve medication adherence in bipolar disorder |
| Q38012647 | Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry |
| Q55434559 | Efficacy of shared decision-making on treatment adherence of patients with bipolar disorder: a cluster randomized trial (ShareD-BD). |
| Q41736063 | Heritability of Transforming Growth Factor-β1 and Tumor Necrosis Factor-Receptor Type 1 Expression and Vitamin D Levels in Healthy Adolescent Twins |
| Q35859092 | Impact of Cannabis Use on Long-Term Remission in Bipolar I and Schizoaffective Disorder |
| Q37958715 | Insight in bipolar disorder |
| Q38168779 | Internet psychoeducation for bipolar affective disorder: basis for preparation and first experiences |
| Q48083750 | Making sense of DSM-5 mania with depressive features |
| Q34300315 | Mania: diagnosis and treatment recommendations |
| Q38902384 | Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review. |
| Q37684910 | Medication adherence in a comparative effectiveness trial for bipolar disorder. |
| Q42931486 | No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations |
| Q38252641 | Optimizing delivery of recovery-oriented online self-management strategies for bipolar disorder: a review |
| Q37960632 | Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review |
| Q37981965 | Palliative models of care for later stages of mental disorder: maximizing recovery, maintaining hope, and building morale |
| Q86863322 | Pharmacist provision of patient medication education groups |
| Q33967329 | Pragmatic randomised controlled trial of group psychoeducation versus group support in the maintenance of bipolar disorder |
| Q37500112 | Predictors of psychotropic medication adherence among HIV+ individuals living with bipolar disorder |
| Q90249291 | Psycho-demographic and clinical predictors of medication adherence in patients with bipolar I disorder in a university hospital in Egypt |
| Q38544047 | Psychosocial treatment and interventions for bipolar disorder: a systematic review |
| Q35117888 | Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder |
| Q37803220 | Risperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorder |
| Q35862776 | Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders |
| Q88200463 | Seasonality, smoking and history of poor treatment compliance are strong predictors of dropout in a naturalistic 6 year follow-up of bipolar patients |
| Q88197328 | Shared Decision-Making: a Systematic Review Focusing on Mood Disorders |
| Q35930169 | Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder |
| Q42654528 | Smartphone Applications for Educating and Helping Non-motivating Patients Adhere to Medication That Treats Mental Health Conditions: Aims and Functioning. |
| Q37533636 | The Effect of Group Psychoeducation Program on Medication Adherence in Patients with Bipolar Mood Disorders: a Randomized Controlled Trial. |
| Q47809503 | The effect of nurse-led motivational interviewing on medication adherence in patients with bipolar disorder |
| Q34360321 | The efficacy of psycho-educational group program on medication adherence and global functioning of patients with bipolar disorder type I. |
| Q38055026 | The nocebo effect: a clinicians guide |
| Q47586296 | The role of depression pharmacogenetic decision support tools in shared decision making. |
| Q37990676 | The science and practice of lithium therapy |
| Q58690945 | Treatment alliance and adherence in bipolar disorder |
| Q39080703 | Treatment-adherence in bipolar disorder: A patient-centred approach |
| Q34652340 | Understanding treatment non-adherence in schizophrenia and bipolar disorder: a survey of what service users do and why. |
| Q42725644 | What's in a name? Compliance, adherence and concordance in chronic psychiatric disorders |
Search more.